52
|
Rebours C, Couloigner V, Galmiche L, Casiraghi O, Badoual C, Boudjemaa S, Chauvin A, Elmaleh M, Fresneau B, Fasola S, Garabédian EN, Van Den Abeele T, Orbach D. Pediatric salivary gland carcinomas: Diagnostic and therapeutic management. Laryngoscope 2016; 127:140-147. [PMID: 27497071 DOI: 10.1002/lary.26204] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2016] [Accepted: 06/27/2016] [Indexed: 02/04/2023]
Abstract
OBJECTIVES/HYPOTHESIS To analyze clinical presentations, treatment modalities, and evolution of pediatric cases of salivary gland carcinomas to standardize care for these rare diseases. STUDY DESIGN Multicentric, retrospective study. METHODS We included in this retrospective study all children and adolescents (aged ≤18 years) treated from 1992 to 2012 in six pediatric centers in Paris, France. Pathological tumor specimens of these cases were reviewed. RESULTS Forty-three children were included (sex ratio male/female = 19/24, median age = 13 years). The parotid gland was the most common (37 cases) location for tumors. Histological subtypes were mucoepidermoid carcinomas (n = 20), acinic cell carcinomas (n = 14), and other (n = 9). Initial fine-needle aspiration was performed in 15 cases (33%), and was concordant to final diagnosis in three cases (20%). Primary surgery was performed in 42 patients, leading to a complete microscopic resection in 80%. Associated lymph node dissection was performed in 28 patients (homolateral: 27, bilateral: 1) and showed lymph node metastases in only two patients. One patient had distant metastases. Adjuvant irradiation was delivered to 11 patients (median: 60 Gy; range: 50-65) and chemotherapy in five cases. After a median follow-up of 5 years, six tumors relapsed, but no deaths occurred. CONCLUSIONS Childhood salivary gland carcinomas have a good prognosis despite possible recurrences. Treatment is mainly based on surgery, with simultaneous node dissection in cases of clinical or radiologic node enlargement. Radiation therapy seems to be restricted to inoperable high-grade tumors or after recurrence. LEVEL OF EVIDENCE 4 Laryngoscope, 127:140-147, 2017.
Collapse
Affiliation(s)
- Céleste Rebours
- Pediatric Ear, Nose, and Throat Department, Necker Hospital for Sick Children, Public Assistance-Hospitals of Paris, Paris, France
| | - Vincent Couloigner
- Pediatric Ear, Nose, and Throat Department, Necker Hospital for Sick Children, Public Assistance-Hospitals of Paris, Paris, France
| | - Louise Galmiche
- Department of Pathology, Necker Hospital for Sick Children, Public Assistance-Hospitals of Paris, Paris, France
| | - Odile Casiraghi
- Department of Pathology, Gustave Roussy Institute, Grand Campus, Villejuif, France
| | - Cécile Badoual
- Department of Pathology, Georges Pompidou European Hospital, Public Assistance-Hospitals of Paris, Paris, France
| | - Sabah Boudjemaa
- Department of Pathology, Armand Trousseau Hospital, Public Assistance-Hospitals of Paris, Paris, France
| | - Anthony Chauvin
- Paris Diderot University, Sorbonne Paris Cité, Public Assistance-Hospitals of Paris, Lariboisière Hospital, Emergency Services, Paris, France
| | - Monique Elmaleh
- Department of Radiology, Robert Debré Hospital, Public Assistance-Hospitals of Paris, Paris, France
| | - Brice Fresneau
- Pediatric Department, Gustave Roussy Institute, Grand Campus, Villejuif, France
| | - Sylvie Fasola
- Hematology and Oncology Department, Armand Trousseau Hospital, Public Assistance-Hospitals of Paris, Paris, France
| | - Erea-Noël Garabédian
- Pediatric Ear, Nose, and Throat Department, Necker Hospital for Sick Children, Public Assistance-Hospitals of Paris, Paris, France
| | - Thierry Van Den Abeele
- Pediatric Ear, Nose, and Throat Department, Robert Debré Hospital, Public Assistance-Hospitals of Paris, Paris, France
| | - Daniel Orbach
- Pediatric, Adolescent, and Young Adult Department, Curie Institute, Paris, France
| | | |
Collapse
|